Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Can pharmaco-electroencephalography help improve survival of central nervous system drugs in early clinical development?

Wilson FJ, Leiser SC, Ivarsson M, Christensen SR, Bastlund JF.

Drug Discov Today. 2014 Mar;19(3):282-8. doi: 10.1016/j.drudis.2013.08.001. Epub 2013 Aug 14. Review.

PMID:
23954252
2.

Early Decision-Making in Drug Development: The Potential Role of Pharmaco-EEG and Pharmaco-Sleep.

Wilson FJ, Danjou P.

Neuropsychobiology. 2015;72(3-4):188-94. doi: 10.1159/000382022. Epub 2016 Feb 23. Review.

PMID:
26900685
3.

Pharmaco-EEG Studies in Animals: A History-Based Introduction to Contemporary Translational Applications.

Drinkenburg WH, Ahnaou A, Ruigt GS.

Neuropsychobiology. 2015;72(3-4):139-50. doi: 10.1159/000443175. Epub 2016 Feb 23. Review.

PMID:
26901675
4.

Pharmaco-electroencephalography in Phase I.

Luthringer R, Boeijinga PH.

Methods Find Exp Clin Pharmacol. 2002;24 Suppl D:95. No abstract available.

PMID:
12809085
5.

Pharmaco-EEG Studies in Animals: An Overview of Contemporary Translational Applications.

Drinkenburg WH, Ruigt GS, Ahnaou A.

Neuropsychobiology. 2015;72(3-4):151-64. doi: 10.1159/000442210. Epub 2016 Feb 23. Review.

PMID:
26901596
6.

Statistical Decision Tree: a tool for studying pharmaco-EEG effects of CNS-active drugs.

Dago KT, Luthringer R, Lengellé R, Rinaudo G, Macher JP.

Neuropsychobiology. 1994;29(2):91-6.

PMID:
8170530
7.

Complementary psychometric methods in pharmaco-electroencephalography research.

Emegbo S, Hindmarch I.

Methods Find Exp Clin Pharmacol. 2002;24 Suppl D:13. No abstract available.

PMID:
12809078
8.

Guidelines for the recording and evaluation of pharmaco-EEG data in man: the International Pharmaco-EEG Society (IPEG).

Jobert M, Wilson FJ, Ruigt GS, Brunovsky M, Prichep LS, Drinkenburg WH; IPEG Pharmaco-EEG Guidelines Committee..

Neuropsychobiology. 2012;66(4):201-20. doi: 10.1159/000343478. Epub 2012 Oct 12. Review.

9.

Translational psychiatry--light at the end of the tunnel.

Jones KA, Menniti FS, Sivarao DV.

Ann N Y Acad Sci. 2015 May;1344:1-11. doi: 10.1111/nyas.12725. Epub 2015 Mar 9. Review.

PMID:
25752480
10.

Aligning strategies for using EEG as a surrogate biomarker: a review of preclinical and clinical research.

Leiser SC, Dunlop J, Bowlby MR, Devilbiss DM.

Biochem Pharmacol. 2011 Jun 15;81(12):1408-21. doi: 10.1016/j.bcp.2010.10.002. Epub 2010 Oct 19. Review.

PMID:
20937262
11.

Guidelines for the recording and evaluation of pharmaco-sleep studies in man: the International Pharmaco-EEG Society (IPEG).

Jobert M, Wilson FJ, Roth T, Ruigt GS, Anderer P, Drinkenburg WH, Bes FW, Brunovsky M, Danker-Hopfe H, Freeman J, van Gerven JM, Gruber G, Kemp B, Klösch G, Ma J, Penzel T, Peterson BT, Schulz H, Staner L, Saletu B, Svetnik V; IPEG Pharmaco-EEG Guidelines Committee..

Neuropsychobiology. 2013;67(3):127-67. doi: 10.1159/000343449. Epub 2013 Mar 16.

12.

Proceedings of the 12th Meeting of the International Pharmaco-EEG Group. Barcelona, Spain, November 21-24, 2002.

[No authors listed]

Methods Find Exp Clin Pharmacol. 2002;24 Suppl D:1-181. No abstract available.

PMID:
12852399
13.

Correct assessment of new compounds using in vivo screening models can reduce false positives.

Bueters TJ, Hoogstraate J, Visser SA.

Drug Discov Today. 2009 Jan;14(1-2):89-94. doi: 10.1016/j.drudis.2008.09.003. Epub 2008 Oct 22. Review.

PMID:
18840543
14.

Proceedings of the 12th Meeting of the International Pharmaco-EEG Group--training course. Barcelona, Spain, November 21-24, 2002.

[No authors listed]

Methods Find Exp Clin Pharmacol. 2002;24 Suppl C:1-142. No abstract available.

PMID:
12852400
15.

The utility of biomarkers in CNS drug development.

Palmer AM.

Drug Discov Today. 2014 Mar;19(3):201-3. doi: 10.1016/j.drudis.2013.11.016. Epub 2013 Nov 26. No abstract available.

PMID:
24291786
16.

Pharmaco-electroencephalography and pharmacokinetic/pharmacodynamic modeling in basic research: focus on human pharmacology.

Valle M, Barbanoj MJ, Jané F.

Methods Find Exp Clin Pharmacol. 2002;24 Suppl D:129-37. Review.

PMID:
12575480
17.

Uses of pharmaco-EEG and pharmacokinetic-pharmacodynamic modeling in the clinical scenario.

Barbanoj MJ, Valle M, Kulisevsky J, Pérez V, Gambús P.

Methods Find Exp Clin Pharmacol. 2002;24 Suppl D:139-44. Review.

PMID:
12575481
18.

CNS drug development - lost in translation?

Talevi A, Bellera CL, Di Ianni M, Gantner M, Bruno-Blanch LE, Castro EA.

Mini Rev Med Chem. 2012 Sep 1;12(10):959-70. Review.

PMID:
22420574
19.

The use of mechanistic biomarkers for evaluating investigational CNS compounds in early drug development.

Soares HD.

Curr Opin Investig Drugs. 2010 Jul;11(7):795-801. Review.

PMID:
20571975
20.

Applications of imaging biomarkers in the early clinical development of central nervous system therapeutic agents.

Cole PE, Schwarz AJ, Schmidt ME.

Clin Pharmacol Ther. 2012 Feb;91(2):315-20. doi: 10.1038/clpt.2011.286. Epub 2012 Jan 4. Review.

PMID:
22218072

Supplemental Content

Support Center